619 filings
Page 2 of 31
8-K
PHIO
Phio Pharmaceuticals Corp
21 Aug 23
Phio Pharmaceuticals Announces Dosing of First
7:30am
8-K
PHIO
Phio Pharmaceuticals Corp
10 Aug 23
Phio Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
4:40pm
10-Q
2023 Q2
PHIO
Phio Pharmaceuticals Corp
Quarterly report
10 Aug 23
4:30pm
8-K
PHIO
Phio Pharmaceuticals Corp
26 Jul 23
Departure of Directors or Certain Officers
4:30pm
4
Robert J Bitterman
5 Jul 23
Phio Pharmaceuticals / Robert J Bitterman ownership change
6:00pm
424B3
PHIO
Phio Pharmaceuticals Corp
20 Jun 23
Prospectus supplement
9:30am
EFFECT
PHIO
Phio Pharmaceuticals Corp
20 Jun 23
Notice of effectiveness
12:15am
4
PHIO
Phio Pharmaceuticals Corp
15 Jun 23
Phio Pharmaceuticals / Robert L Ferrara ownership change
5:00pm
CORRESP
PHIO
Phio Pharmaceuticals Corp
14 Jun 23
Correspondence with SEC
12:00am
UPLOAD
PHIO
Phio Pharmaceuticals Corp
14 Jun 23
Letter from SEC
12:00am
D
PHIO
Phio Pharmaceuticals Corp
13 Jun 23
$10.91 mm in equity / options / securities to be acquired, sold $3.00 mm, 3 investors
4:40pm
ARS
2022 FY
PHIO
Phio Pharmaceuticals Corp
9 Jun 23
Annual report to shareholders
4:32pm
DEFA14A
PHIO
Phio Pharmaceuticals Corp
9 Jun 23
Additional proxy soliciting materials
4:31pm
DEF 14A
PHIO
Phio Pharmaceuticals Corp
Definitive proxy
9 Jun 23
4:30pm
S-1
PHIO
Phio Pharmaceuticals Corp
IPO registration
8 Jun 23
5:00pm
8-K
PHIO
Phio Pharmaceuticals Corp
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
424B5
PHIO
Phio Pharmaceuticals Corp
1 Jun 23
Prospectus supplement for primary offering
5:00pm
8-K
PHIO
Phio Pharmaceuticals Corp
24 May 23
One of two newly announced clinical trials for its lead product candidate, PH-762
7:35am
8-K
PHIO
Phio Pharmaceuticals Corp
16 May 23
Phio Pharmaceuticals Announces FDA Clearance to Initiate
7:35am
8-K
PHIO
Phio Pharmaceuticals Corp
11 May 23
Phio Pharmaceuticals Reports First Quarter 2023 Financial
5:02pm